Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Disease-A-Month : DM
|
April 26, 2016
Human papillomavirus infection
Jack N Hutter, Catherine F Decker
Tropical Diseases, Travel Medicine and Vaccines
|
September 9, 2017
Guidelines for the prevention of travel-associated illness in older adults
Tida K Lee, Jack N Hutter, Jennifer Masel, et al.
Medical Journal (Fort Sam Houston, Tex.)
|
March 5, 2021
Deployment of the 1st Area Medical Laboratory to South Korea in Response to the COVID-19 Pandemic
William Washington, Jack N Hutter, Christine E Hulseberg, et al.
Vaccine
|
December 14, 2020
Systematic review of Marburg virus vaccine nonhuman primate studies and human clinical trials
Nicholas Dulin, Adam Spanier, Kristen Merino, et al.
The American Journal of Tropical Medicine and Hygiene
|
April 23, 2024
The Walter Reed Project, Kisumu Field Station: Impact of Research on Malaria Policy, Management, and Prevention
Peter M Sifuna, Michal Mbinji, Tina O Lucas, et al.
JMM Case Reports
|
January 9, 2019
Bacteraemia due to <i>Microbacterium paraoxydans</i> in a patient with chronic kidney disease, refractory hypertension and sarcoidosis
Matthew S Chorost, Nancy C Smith, Jack N Hutter, et al.
NPJ Vaccines
|
November 17, 2024
Phase 1 clinical trial of Hantaan and Puumala virus DNA vaccines delivered by needle-free injection
Jay W Hooper, Steven A Kwilas, Matthew Josleyn, et al.
The Journal of Infectious Diseases
|
August 2, 2025
Plasmodium falciparum Parasitemia Does Not Diminish Neutralizing Antibody Responses After mRNA COVID-19 Booster Vaccination in HIV-infected Adults
Taraz Samandari, Millicent Achola, Jack N Hutter, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 5, 2025
Neutralizing Antibody Responses After mRNA COVID-19 Booster Vaccination are Unaffected by Parasitemia in a Malaria-Endemic Setting
Taraz Samandari, Millicent Achola, Jack N Hutter, et al.
Vaccine
|
September 2, 2022
First-in-human assessment of safety and immunogenicity of low and high doses of Plasmodium falciparum malaria protein 013 (FMP013) administered intramuscularly with ALFQ adjuvant in healthy malaria-naïve adults
Jack N Hutter, Paul M Robben, Christine Lee, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Disease-A-Month : DM
|
April 26, 2016
Human papillomavirus infection
Jack N Hutter, Catherine F Decker
Tropical Diseases, Travel Medicine and Vaccines
|
September 9, 2017
Guidelines for the prevention of travel-associated illness in older adults
Tida K Lee, Jack N Hutter, Jennifer Masel, et al.
Medical Journal (Fort Sam Houston, Tex.)
|
March 5, 2021
Deployment of the 1st Area Medical Laboratory to South Korea in Response to the COVID-19 Pandemic
William Washington, Jack N Hutter, Christine E Hulseberg, et al.
Vaccine
|
December 14, 2020
Systematic review of Marburg virus vaccine nonhuman primate studies and human clinical trials
Nicholas Dulin, Adam Spanier, Kristen Merino, et al.
The American Journal of Tropical Medicine and Hygiene
|
April 23, 2024
The Walter Reed Project, Kisumu Field Station: Impact of Research on Malaria Policy, Management, and Prevention
Peter M Sifuna, Michal Mbinji, Tina O Lucas, et al.
JMM Case Reports
|
January 9, 2019
Bacteraemia due to <i>Microbacterium paraoxydans</i> in a patient with chronic kidney disease, refractory hypertension and sarcoidosis
Matthew S Chorost, Nancy C Smith, Jack N Hutter, et al.
NPJ Vaccines
|
November 17, 2024
Phase 1 clinical trial of Hantaan and Puumala virus DNA vaccines delivered by needle-free injection
Jay W Hooper, Steven A Kwilas, Matthew Josleyn, et al.
The Journal of Infectious Diseases
|
August 2, 2025
Plasmodium falciparum Parasitemia Does Not Diminish Neutralizing Antibody Responses After mRNA COVID-19 Booster Vaccination in HIV-infected Adults
Taraz Samandari, Millicent Achola, Jack N Hutter, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 5, 2025
Neutralizing Antibody Responses After mRNA COVID-19 Booster Vaccination are Unaffected by Parasitemia in a Malaria-Endemic Setting
Taraz Samandari, Millicent Achola, Jack N Hutter, et al.
Vaccine
|
September 2, 2022
First-in-human assessment of safety and immunogenicity of low and high doses of Plasmodium falciparum malaria protein 013 (FMP013) administered intramuscularly with ALFQ adjuvant in healthy malaria-naïve adults
Jack N Hutter, Paul M Robben, Christine Lee, et al.
Page
of 2